Page last updated: 2024-11-11

1-hydroxy-2,3,5-trimethoxyxanthene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-hydroxy-2,3,5-trimethoxyxanthene: from Swertia tetrapetala Pall; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
SwertiagenusA plant genus of the family GENTIANACEAE. It is a source of swertiapuniside and IRIDOID GLYCOSIDES.[MeSH]GentianaceaeA plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.[MeSH]
Swertia tetrapetalaspecies[no description available]GentianaceaeA plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.[MeSH]

Cross-References

ID SourceID
PubMed CID5318372
SCHEMBL ID18240045
MeSH IDM0106003

Synonyms (14)

Synonym
xanthone, 1-hydroxy-2,3,5-trimethoxy-
1-hydroxy-2,3,5-trimethoxyxanthen-9-one
9h-xanthen-9-one, 1-hydroxy-2,3,5-trimethoxy-
1-hydroxy-2,3,5-trimethoxyxanthene
22804-49-5
1-htmx
1-hydroxy-2,3,5-trimethoxyxanthone
SCHEMBL18240045
AKOS025288392
FFVKXGZKJBHJMS-UHFFFAOYSA-N
FS-8758
DTXSID80945485
1-hydroxy-2,3,5-trimethoxy-9h-xanthen-9-one
1-hydroxy-2,3,5-trimethoxy-9h-xanthen-9-one;tovopyrifolin c 3,5-di-o-methyl ether
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's1 (11.11)18.2507
2000's4 (44.44)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.48 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]